[
  {
    "ts": null,
    "headline": "DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM",
    "summary": "Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into DexCom, Inc. .On July...",
    "url": "https://finnhub.io/api/news?id=104756f186996d6eaa55c69b47cdba533c4ad14b43c0019fdf78a010fe1c4f51",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734783843,
      "headline": "DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM",
      "id": 132097922,
      "image": "",
      "related": "DXCM",
      "source": "Finnhub",
      "summary": "Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC , announces that KSF has commenced an investigation into DexCom, Inc. .On July...",
      "url": "https://finnhub.io/api/news?id=104756f186996d6eaa55c69b47cdba533c4ad14b43c0019fdf78a010fe1c4f51"
    }
  },
  {
    "ts": null,
    "headline": "1 Reason to Sell DexCom Stock, and 1 Reason to Buy",
    "summary": "Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year.  The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive drop in its stock price overnight.  On the other hand, DexCom has attractive opportunities that could allow it to deliver market-beating returns to patient investors.",
    "url": "https://finnhub.io/api/news?id=2044c9fa38793654ebf7c2cec7ad35442f326fe3eb83303567310a384bcfc2d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734781500,
      "headline": "1 Reason to Sell DexCom Stock, and 1 Reason to Buy",
      "id": 132097524,
      "image": "https://g.foolcdn.com/editorial/images/801479/diabetes-patient-adjusting-device.jpg",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year.  The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive drop in its stock price overnight.  On the other hand, DexCom has attractive opportunities that could allow it to deliver market-beating returns to patient investors.",
      "url": "https://finnhub.io/api/news?id=2044c9fa38793654ebf7c2cec7ad35442f326fe3eb83303567310a384bcfc2d9"
    }
  }
]